4 Results for "

MLN2238

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "MLN2238" in MCE Product Catalog:

23
23 Cited Publications
Cat. No.: HY-10453
CAS No.: 1072833-77-2
Purity:  99.30%
Synonyms: MLN2238
Target:  

Proteasome Autophagy

Research Areas:  

Cancer

Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM).
loading...
    loading...
Cat. No.: HY-10453R
CAS No.: 1072833-77-2
Synonyms: MLN2238 (Standard)
Research Areas:  

Cancer

Ixazomib (Standard) is the analytical standard of Ixazomib. This product is intended for research and analytical applications. Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM).
loading...
    loading...
Cat. No.: HY-W748328
Ixazomib- 13C2, 15N is 13C and 15N labeled Ixazomib. Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM) .
loading...
    loading...
Cat. No.: HY-10453S
CAS No.: 2177240-89-8
Synonyms: MLN2238-d7
Ixazomib-d7 is the deuterium labeled Ixazomib (HY-10453). Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM) .
loading...
    loading...